Viewing Study NCT03988933


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2025-12-30 @ 4:52 AM
Study NCT ID: NCT03988933
Status: COMPLETED
Last Update Posted: 2025-06-04
First Post: 2019-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.
Sponsor:
Organization: